06.10.24 -- Understanding FDA's Draft Guidance On Human- And Animal-Derived Materials In The Manufacture Of CGT Products

Uncover how leveraging platform processes can enable flexible service at each level – pre-clinical through commercial – and reduce development timelines and costs on the path to market.

Learn how researchers are leveraging CRISPR nucleases, employing single cell cloning techniques, optimizing delivery methods, and refining guide RNA design to enhance the safety and efficacy of iPSCs.

Employee turnover, even during complex clinical trials, should never be the breaking point of a project. Avoid these instances and keep studies on track by developing proactive employee retention strategies.

Examine the drivers behind the recent successes in the clinic, current challenges with development and manufacturing, and what the future might hold for the ADC industry.

Explore the latest market trends and the nuances of various cell and gene therapy modalities, along with the logistical considerations necessary to safeguard product quality and safety.

As you search for a supplier best suited to help manufacture your product, prioritize the CDMO with previous plasmid production experience needed to avoid common manufacturing obstacles.